C16H24O5
Neat
296.36
Ovalicin; 19683-98-8; XBF6GMZ9TW; (3S, 4R, 5S)-4-hydroxy-5-methoxy-4-[(2S, 3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-one; (3S, 4R, 5S)-4-Hydroxy-5-methoxy-4-((2S, 3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl)-1-oxaspiro(2.5)octan-6-one; (3S, 4R, 5S)-4-hydroxy-5-methoxy-4-((2S, 3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-one; (3S, 4R, 5S)-4-Hydroxy-5-methoxy-4-[(2S, 3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]octan-6-one; RefChem:208344; (3S, 4R, 5S)-4-hydroxy-5-methoxy-4-((2S)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-one; Graphinone; (-)-Ovalicin; CHEMBL562231; 1-Oxaspiro(2, 5)octan-6-one, 4-(1, 2-epoxy-1, 5-dimethyl-4-hexenyl)-4-hydroxy-5-methoxy-, (1S, 2R, 3S, 4R, 5S)-(-)-; UNII-XBF6GMZ9TW; orb2565606; SCHEMBL15624476; BDBM50295172; 1-Oxaspiro[2.5]octan-6-one, 4-(1, 2-epoxy-1, 5-dimethyl-4-hexenyl)-4-hydroxy-5-methoxy-, (1S, 2R, 3S, 4R and 5S)-(-)-; HY-156959; CS-0904954
(3S, 4R, 5S)-4-hydroxy-5-methoxy-4-[(2S and 3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-one
InChI=1S/C16H24O5/c1-10(2)5-6-12-14(3,21-12)16(18)13(19-4)11(17)7-8-15(16)9-20-15/h5,12-13,18H,6-9H2,1-4H3/t12-,13-,14+,15+,16+/m1/s1